Lundbeck has commenced a Phase III trial to evaluate the safety and efficacy of the human monoclonal antibody in treating MSA. Credit: Copyright© 2025 H. Lundbeck A ...

VALBY, Denmark, March 10, 2025 /PRNewswire/ -- The Ministry of Health, Labor, and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD) to Lundbeck's investigational drug, amlenetug ...

VALBY, Denmark, March 10, 2025 /PRNewswire/ -- The Ministry of Health, Labor, and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD) to Lundbeck's investigational drug, amlenetug ...

The Ministry of Health, Labor, and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD) to Lundbeck’s investigational drug, amlenetug, a potential new treatment option targeting Multiple ...

BANGKOK, March 10 (Reuters) - Malaysia has warned its citizens against travelling to southern Thailand after bombings and shootings by suspected insurgents killed five people and injured 13 others ...

Lundbeck’s digital strategy is looking at the different channels that we have and using one platform for all of our channels. This is essential for us at global HQ and our affiliates as well.

HOW can Malaysia learn from its past to build a better future? This question set the tone at a book talk on How Malaysia Missed 7 Chances at Nation Building by former banker Datuk Mohammed Hussein.

KUALA LUMPUR, Feb 25 — Malaysia is committed to positioning ASEAN as a global leader in sustainable finance and will advocate for deeper collaboration in green financing, regional energy connectivity, ...

KUALA LUMPUR, Feb 25 (Reuters) - Malaysia had approved investments of 378.5 billion ringgit ($85.8 billion) in 2024, a record figure and an increase of 14.9% from the previous year, its trade ...